is semaglutide glp-1 New Demand in an Old Market Outlook for obesity in 2025:
Description
Tramunt, E
Ozempic (semaglutide) is a medication primarily used to manage type 2 diabetes
Accepted: Published: Version of record: DOI:
[DOI] [PMC free article] [PubMed] [Google Scholar] 71
The purpose of this analysis is to measure GLP-1 obesity treatment persistence, adherence, and switching in a real-world cohort of members without diabetes using these drugs
Along with reports showing that GLP-1R agonists induce hypothalamic POMC activity 49 and our observation that weight loss induced by GLP-1GIPLani is markedly diminished in Vglut2 / Glp1r -knockout mice (Fig
